Hello

Hey! How can I help you today?

What is osteoporosis

Reading File

Finding Sources

Searching PubMed

osteoporosis diagnosis treatment

Reading File

Finding Sources

Reading File

I now have very comprehensive textbook content. Let me compile the full answer.

Osteoporosis

Definition

Osteoporosis is a skeletal disorder characterized by both reduced bone quantity (low bone mass) and reduced bone quality (microarchitectural deterioration of bone tissue), resulting in increased bone fragility and a greater risk of fracture. The WHO operationally defines it as a bone mineral density (BMD) that falls 2.5 or more standard deviations below the mean for young healthy adults of the same sex and race - expressed as a T-score of -2.5 or less, measured by dual-energy X-ray absorptiometry (DXA).

Normal BMD: T-score above -1.0
Osteopenia (low bone mass): T-score between -1.0 and -2.5
Osteoporosis: T-score at or below -2.5
Severe osteoporosis: T-score at or below -2.5 plus a fragility fracture

Harrison's Principles of Internal Medicine 22E, p.1783; Rheumatology 2-Volume Set, p.2325

Epidemiology

In the United States, approximately 10.8 million women and 2.5 million men have osteoporosis
About 2 million osteoporosis-related fractures occur every year in the US, costing ~$19 billion
An additional 40 million Americans have osteopenia, placing them at elevated fracture risk
30% of fragility fractures occur in men (often underdiagnosed)
Globally, hip fractures are increasing as populations age

Harrison's, p.1788

Pathophysiology

Bone is in a constant cycle of remodeling - osteoclasts resorb old bone while osteoblasts form new bone. Two key molecular systems govern this:

RANK/RANKL/Osteoprotegerin axis: Osteocytes and osteoblasts secrete RANKL (a TNF family member), which binds RANK on osteoclasts to activate bone resorption. Osteoprotegerin acts as a decoy receptor, blocking this process. An imbalance (excess RANKL or reduced OPG) drives excess resorption.
Wnt signaling pathway: Promotes osteoblast activity and bone formation. Sclerostin (an osteocyte protein) inhibits Wnt and is itself inhibited by weight-bearing exercise and PTH.

In young adults, resorption and formation are balanced. After age 30-45, resorption begins to outpace formation, accelerated in women by estrogen deficiency after menopause. In trabecular bone, osteoclasts can penetrate and destroy trabeculae entirely, disconnecting the trabecular network. In cortical bone, increased porosity develops. The result is both reduced mass and disrupted microarchitecture - bones that are weaker than their density alone would suggest.

Harrison's, pp.1871-1876

Risk Factors

Category	Factors
Non-modifiable	Advanced age, female sex, White/Asian ethnicity, family history of osteoporosis/hip fracture, early menopause (<45 years)
Modifiable	Low calcium intake, vitamin D deficiency, smoking, excessive alcohol, physical inactivity, low body weight
Secondary causes	Glucocorticoid use (>5 mg prednisone/day for >3 months), rheumatoid arthritis, malabsorption (celiac disease), chronic kidney disease, hyperthyroidism, hypogonadism

Clinical Manifestations

Osteoporosis is often called a "silent disease" - bone loss occurs without symptoms until a fracture happens. Common presentations include:

Vertebral compression fractures - the most common type; ~70% are asymptomatic. Can cause height loss and progressive kyphosis ("dowager's hump")
Hip fractures - associated with high mortality and morbidity in the elderly
Wrist (Colles') fractures - often the first fracture in a younger osteoporotic patient
Back pain and loss of height are late signs

Diagnosis

1. DXA Scan (Gold Standard)

Dual-energy X-ray absorptiometry of the hip and lumbar spine is the primary diagnostic tool. Results are reported as T-scores (compared to young healthy adults) and Z-scores (compared to age-matched peers). Z-scores are preferred in premenopausal women, men under 50, and children.

2. FRAX Score

The WHO Fracture Risk Assessment Tool combines clinical risk factors (age, prior fracture, family history, BMI, smoking, alcohol, glucocorticoid use, rheumatoid arthritis) with or without BMD to estimate 10-year probability of major osteoporotic fracture or hip fracture. In the US, treatment is indicated if:

10-year hip fracture risk ≥3%, or
10-year major osteoporotic fracture risk ≥20%

3. Vertebral Fracture Assessment (VFA)

A DXA-based lateral spine imaging technique, important since the majority of vertebral fractures are asymptomatic.

Harrison's, pp.1993-2007; Rheumatology, pp.2356-2362

Treatment

Non-Pharmacological

Calcium: 1,000-1,200 mg/day (dietary + supplement)
Vitamin D: 800-1,000 IU/day
Weight-bearing exercise: stimulates bone formation and reduces fall risk
Fall prevention: home hazard removal, balance training, hip protectors
Smoking cessation, limit alcohol

Pharmacological

Drug Class	Examples	Mechanism
Bisphosphonates (first-line)	Alendronate, risedronate, zoledronic acid	Inhibit osteoclast-mediated resorption
Denosumab	Prolia	Monoclonal antibody against RANKL; inhibits osteoclast formation
Teriparatide / Abaloparatide	Forteo, Tymlos	PTH analogs; anabolic - stimulate bone formation
Romosozumab	Evenity	Anti-sclerostin antibody; dual action (stimulates formation, reduces resorption)
SERMs	Raloxifene	Estrogen receptor modulator; reduces vertebral fracture risk
HRT	Estrogen	Reduces bone resorption; used primarily for menopausal symptoms

A recent meta-analysis (PMID 39312040) found that teriparatide and denosumab are each superior to bisphosphonates in treatment-naive osteoporosis patients.

Key Takeaways

Osteoporosis = reduced bone mass + microarchitectural deterioration = fragility fractures
Defined by T-score ≤ -2.5 on DXA; T-score -1.0 to -2.5 = osteopenia
Driven by imbalance between osteoclast resorption and osteoblast formation (RANKL/Wnt pathways)
Most fractures occur in the hip, spine, and wrist; vertebral fractures are often asymptomatic
Treatment involves lifestyle measures + anti-resorptive or anabolic pharmacotherapy based on fracture risk

Make ppt of this topic very attractive ppt

Reading File

Running Command

ls /home/daytona/workspace/ 2>/dev/null || echo "workspace empty"

Running Command

mkdir -p /home/daytona/workspace/osteoporosis-ppt

Writing File

~/osteoporosis-ppt/create_ppt.js

const pptxgen = require("pptxgenjs");

const pres = new pptxgen();
pres.layout = "LAYOUT_16x9";
pres.title = "Osteoporosis";
pres.author = "Medical Presentation";

// ─── COLOR PALETTE ───────────────────────────────────────────────────────────
// Deep teal / navy dominant palette with coral/amber accents — clinical and modern
const C = {
  navy:      "0D2B45",  // dominant dark bg
  teal:      "1A6B8A",  // supporting mid
  tealLight: "2A9BBF",  // accent
  coral:     "E8724A",  // sharp accent
  amber:     "F5A623",  // warm highlight
  white:     "FFFFFF",
  offWhite:  "F0F4F8",
  lightGray: "D8E4EC",
  darkText:  "1A2B3C",
  midGray:   "7A9AB0",
};

// ─── HELPER: dark section header bar ─────────────────────────────────────────
function addSlideHeader(slide, title, subtitle) {
  // Full-width dark bar at top
  slide.addShape(pres.shapes.RECTANGLE, {
    x: 0, y: 0, w: 10, h: 1.15,
    fill: { color: C.navy }, line: { color: C.navy }
  });
  // Coral accent strip
  slide.addShape(pres.shapes.RECTANGLE, {
    x: 0, y: 1.15, w: 10, h: 0.07,
    fill: { color: C.coral }, line: { color: C.coral }
  });
  slide.addText(title, {
    x: 0.4, y: 0.1, w: 9.2, h: 0.7,
    fontSize: 26, bold: true, color: C.white,
    fontFace: "Calibri", valign: "middle", margin: 0
  });
  if (subtitle) {
    slide.addText(subtitle, {
      x: 0.4, y: 0.75, w: 9.2, h: 0.4,
      fontSize: 13, color: C.tealLight,
      fontFace: "Calibri", valign: "middle", margin: 0
    });
  }
}

// ─── HELPER: card ─────────────────────────────────────────────────────────────
function addCard(slide, x, y, w, h, title, body, accentColor) {
  const ac = accentColor || C.teal;
  // card bg
  slide.addShape(pres.shapes.RECTANGLE, {
    x, y, w, h,
    fill: { color: C.offWhite },
    line: { color: C.lightGray, pt: 1 },
    shadow: { type: "outer", color: "000000", blur: 8, offset: 3, angle: 135, opacity: 0.12 }
  });
  // left accent bar
  slide.addShape(pres.shapes.RECTANGLE, {
    x, y, w: 0.06, h,
    fill: { color: ac }, line: { color: ac }
  });
  // card title
  slide.addText(title, {
    x: x + 0.14, y: y + 0.06, w: w - 0.2, h: 0.35,
    fontSize: 13, bold: true, color: ac,
    fontFace: "Calibri", valign: "top", margin: 0
  });
  // card body
  slide.addText(body, {
    x: x + 0.14, y: y + 0.42, w: w - 0.2, h: h - 0.5,
    fontSize: 11, color: C.darkText,
    fontFace: "Calibri", valign: "top", margin: 0
  });
}

// ─── HELPER: icon circle ──────────────────────────────────────────────────────
function addIconCircle(slide, x, y, r, icon, bgColor) {
  slide.addShape(pres.shapes.OVAL, {
    x: x - r, y: y - r, w: r * 2, h: r * 2,
    fill: { color: bgColor || C.teal },
    line: { color: bgColor || C.teal }
  });
  slide.addText(icon, {
    x: x - r, y: y - r, w: r * 2, h: r * 2,
    fontSize: r * 18, color: C.white,
    fontFace: "Segoe UI Emoji", align: "center", valign: "middle", margin: 0
  });
}

// ─── SLIDE 1: TITLE ──────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  // Full dark bg
  s.addShape(pres.shapes.RECTANGLE, {
    x: 0, y: 0, w: 10, h: 5.625,
    fill: { color: C.navy }, line: { color: C.navy }
  });
  // Right decorative teal panel
  s.addShape(pres.shapes.RECTANGLE, {
    x: 6.8, y: 0, w: 3.2, h: 5.625,
    fill: { color: C.teal }, line: { color: C.teal }
  });
  // Coral diagonal accent stripe
  s.addShape(pres.shapes.RECTANGLE, {
    x: 6.5, y: 0, w: 0.12, h: 5.625,
    fill: { color: C.coral }, line: { color: C.coral }
  });
  // Decorative circles (bone-like)
  s.addShape(pres.shapes.OVAL, {
    x: 7.2, y: 0.3, w: 1.8, h: 1.8,
    fill: { color: "FFFFFF", transparency: 88 }, line: { color: "FFFFFF", transparency: 80, pt: 1 }
  });
  s.addShape(pres.shapes.OVAL, {
    x: 8.1, y: 2.5, w: 1.2, h: 1.2,
    fill: { color: "FFFFFF", transparency: 85 }, line: { color: "FFFFFF", transparency: 80, pt: 1 }
  });
  s.addShape(pres.shapes.OVAL, {
    x: 6.9, y: 3.6, w: 0.8, h: 0.8,
    fill: { color: C.amber, transparency: 40 }, line: { color: C.amber, transparency: 40, pt: 1 }
  });

  // OSTEOPOROSIS title
  s.addText("OSTEOPOROSIS", {
    x: 0.5, y: 1.2, w: 6.0, h: 1.3,
    fontSize: 48, bold: true, color: C.white,
    fontFace: "Calibri", charSpacing: 4, valign: "middle"
  });
  // Coral underline
  s.addShape(pres.shapes.RECTANGLE, {
    x: 0.5, y: 2.55, w: 4.5, h: 0.07,
    fill: { color: C.coral }, line: { color: C.coral }
  });
  // Subtitle
  s.addText("Understanding Bone Health, Fragility & Treatment", {
    x: 0.5, y: 2.7, w: 6.0, h: 0.55,
    fontSize: 16, color: C.tealLight,
    fontFace: "Calibri", italic: true
  });
  // Tag line pills
  const tags = ["10.8M affected in US", "Silent Disease", "Preventable & Treatable"];
  tags.forEach((tag, i) => {
    const tx = 0.5 + i * 2.0;
    s.addShape(pres.shapes.ROUNDED_RECTANGLE, {
      x: tx, y: 3.5, w: 1.85, h: 0.38,
      fill: { color: C.coral }, line: { color: C.coral }, rectRadius: 0.05
    });
    s.addText(tag, {
      x: tx, y: 3.5, w: 1.85, h: 0.38,
      fontSize: 10, bold: true, color: C.white,
      fontFace: "Calibri", align: "center", valign: "middle", margin: 0
    });
  });
  // Source
  s.addText("Source: Harrison's Principles of Internal Medicine 22E (2025)", {
    x: 0.5, y: 5.1, w: 6.0, h: 0.3,
    fontSize: 9, color: C.midGray, fontFace: "Calibri", italic: true
  });
}

// ─── SLIDE 2: DEFINITION ─────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: C.offWhite }, line: { color: C.offWhite } });
  addSlideHeader(s, "Definition & Classification", "What is Osteoporosis?");

  // Big definition block
  s.addShape(pres.shapes.RECTANGLE, {
    x: 0.35, y: 1.4, w: 9.3, h: 1.05,
    fill: { color: C.navy }, line: { color: C.navy },
    shadow: { type: "outer", color: "000000", blur: 10, offset: 3, angle: 135, opacity: 0.18 }
  });
  s.addText('"A skeletal disorder characterized by reduced bone quantity and quality, resulting in increased fragility and fracture risk."', {
    x: 0.5, y: 1.42, w: 9.0, h: 1.0,
    fontSize: 14, italic: true, color: C.white,
    fontFace: "Calibri", align: "center", valign: "middle", margin: 0
  });

  // T-score classification cards
  const classes = [
    { label: "Normal", tscore: "T-score > -1.0", color: "27AE60", icon: "✔" },
    { label: "Osteopenia", tscore: "T-score -1.0 to -2.5", color: C.amber, icon: "⚠" },
    { label: "Osteoporosis", tscore: "T-score ≤ -2.5", color: C.coral, icon: "⬇" },
    { label: "Severe", tscore: "T-score ≤ -2.5 + Fracture", color: "8E1B1B", icon: "☠" },
  ];
  classes.forEach((c, i) => {
    const cx = 0.35 + i * 2.38;
    s.addShape(pres.shapes.RECTANGLE, {
      x: cx, y: 2.65, w: 2.2, h: 1.55,
      fill: { color: c.color },
      line: { color: c.color },
      shadow: { type: "outer", color: "000000", blur: 6, offset: 2, angle: 135, opacity: 0.15 }
    });
    s.addText(c.icon, {
      x: cx, y: 2.65, w: 2.2, h: 0.55,
      fontSize: 22, color: C.white, align: "center", valign: "middle",
      fontFace: "Segoe UI Emoji", margin: 0
    });
    s.addText(c.label, {
      x: cx, y: 3.2, w: 2.2, h: 0.45,
      fontSize: 13, bold: true, color: C.white,
      fontFace: "Calibri", align: "center", valign: "middle", margin: 0
    });
    s.addText(c.tscore, {
      x: cx, y: 3.65, w: 2.2, h: 0.55,
      fontSize: 10, color: C.white,
      fontFace: "Calibri", align: "center", valign: "top", margin: 0
    });
  });

  // WHO caption
  s.addText("WHO Diagnostic Classification via DXA (Dual-energy X-ray Absorptiometry)", {
    x: 0.35, y: 5.05, w: 9.3, h: 0.3,
    fontSize: 10, color: C.midGray, fontFace: "Calibri", italic: true, align: "center"
  });
}

// ─── SLIDE 3: EPIDEMIOLOGY ────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: C.offWhite }, line: { color: C.offWhite } });
  addSlideHeader(s, "Epidemiology", "The Scale of the Problem");

  // Big stat blocks
  const stats = [
    { num: "10.8M", lbl: "Women with\nOsteoporosis (US)", col: C.teal },
    { num: "2.5M", lbl: "Men with\nOsteoporosis (US)", col: C.tealLight },
    { num: "40M", lbl: "Americans with\nOsteopenia", col: C.amber },
    { num: "$19B", lbl: "Annual Cost of\nFractures (US)", col: C.coral },
    { num: "2M", lbl: "Fractures per\nyear (US)", col: "8E44AD" },
  ];
  stats.forEach((st, i) => {
    const col = i < 3 ? 0.3 + i * 3.2 : 1.7 + (i - 3) * 3.2;
    const row = i < 3 ? 1.35 : 3.2;
    s.addShape(pres.shapes.RECTANGLE, {
      x: col, y: row, w: 2.85, h: 1.55,
      fill: { color: st.col },
      line: { color: st.col },
      shadow: { type: "outer", color: "000000", blur: 8, offset: 3, angle: 135, opacity: 0.18 }
    });
    s.addText(st.num, {
      x: col, y: row + 0.08, w: 2.85, h: 0.8,
      fontSize: 32, bold: true, color: C.white,
      fontFace: "Calibri", align: "center", valign: "middle", margin: 0
    });
    s.addText(st.lbl, {
      x: col, y: row + 0.88, w: 2.85, h: 0.6,
      fontSize: 11, color: C.white,
      fontFace: "Calibri", align: "center", valign: "top", margin: 0
    });
  });

  s.addText("30% of fragility fractures occur in men   |   >50% of fractures in postmenopausal women have osteopenia, not osteoporosis", {
    x: 0.3, y: 5.1, w: 9.4, h: 0.3,
    fontSize: 9.5, color: C.midGray, fontFace: "Calibri", italic: true, align: "center"
  });
}

// ─── SLIDE 4: PATHOPHYSIOLOGY ─────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: C.navy }, line: { color: C.navy } });

  // Header (dark slide — custom header)
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 0, w: 10, h: 1.0, fill: { color: "091D30" }, line: { color: "091D30" } });
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 1.0, w: 10, h: 0.07, fill: { color: C.coral }, line: { color: C.coral } });
  s.addText("Pathophysiology", {
    x: 0.4, y: 0.1, w: 9.2, h: 0.55, fontSize: 26, bold: true, color: C.white, fontFace: "Calibri", valign: "middle", margin: 0
  });
  s.addText("Bone Remodeling Imbalance — RANK/RANKL & Wnt Pathways", {
    x: 0.4, y: 0.62, w: 9.2, h: 0.38, fontSize: 13, color: C.tealLight, fontFace: "Calibri", valign: "middle", margin: 0, italic: true
  });

  // Flow diagram: 3 boxes with arrows
  const boxes = [
    { x: 0.3, title: "Osteoclast Activation", body: "RANKL binds RANK receptor\non osteoclasts → bone\nresorption accelerates", icon: "⬆", col: C.coral },
    { x: 3.55, title: "Imbalanced Remodeling", body: "After age 30-45, resorption\nexceeds formation. Estrogen\ndeficiency worsens in women.", icon: "⚖", col: C.amber },
    { x: 6.8, title: "Microarchitecture Loss", body: "Trabecular perforation,\ncortical porosity, reduced\nskeletal strength", icon: "🦴", col: C.tealLight },
  ];
  boxes.forEach((b) => {
    s.addShape(pres.shapes.RECTANGLE, {
      x: b.x, y: 1.25, w: 3.0, h: 3.9,
      fill: { color: "112233" }, line: { color: b.col, pt: 2 },
      shadow: { type: "outer", color: "000000", blur: 12, offset: 4, angle: 135, opacity: 0.3 }
    });
    // Top accent strip
    s.addShape(pres.shapes.RECTANGLE, {
      x: b.x, y: 1.25, w: 3.0, h: 0.07,
      fill: { color: b.col }, line: { color: b.col }
    });
    // Icon circle
    s.addShape(pres.shapes.OVAL, {
      x: b.x + 1.1, y: 1.38, w: 0.8, h: 0.8,
      fill: { color: b.col }, line: { color: b.col }
    });
    s.addText(b.icon, {
      x: b.x + 1.1, y: 1.38, w: 0.8, h: 0.8,
      fontSize: 18, color: C.white, fontFace: "Segoe UI Emoji",
      align: "center", valign: "middle", margin: 0
    });
    s.addText(b.title, {
      x: b.x + 0.1, y: 2.28, w: 2.8, h: 0.5,
      fontSize: 13, bold: true, color: b.col,
      fontFace: "Calibri", align: "center", valign: "middle", margin: 0
    });
    s.addText(b.body, {
      x: b.x + 0.15, y: 2.85, w: 2.7, h: 1.5,
      fontSize: 11.5, color: C.white,
      fontFace: "Calibri", align: "center", valign: "top", margin: 0
    });
  });

  // Arrows between boxes
  [1, 2].forEach((i) => {
    s.addShape(pres.shapes.RECTANGLE, {
      x: 3.3 + (i - 1) * 3.25, y: 3.1, w: 0.25, h: 0.06,
      fill: { color: C.midGray }, line: { color: C.midGray }
    });
    s.addText("▶", {
      x: 3.3 + (i - 1) * 3.25, y: 2.98, w: 0.25, h: 0.3,
      fontSize: 12, color: C.midGray, align: "right", valign: "middle", margin: 0
    });
  });

  // Bottom note
  s.addText("Osteoprotegerin (OPG) acts as decoy receptor, blocking RANKL. Wnt signaling promotes osteoblast formation; sclerostin inhibits Wnt.", {
    x: 0.3, y: 5.2, w: 9.4, h: 0.3,
    fontSize: 9.5, color: C.midGray, fontFace: "Calibri", italic: true, align: "center"
  });
}

// ─── SLIDE 5: RISK FACTORS ────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: C.offWhite }, line: { color: C.offWhite } });
  addSlideHeader(s, "Risk Factors", "Who is at Risk?");

  const categories = [
    {
      title: "Non-Modifiable",
      color: C.teal,
      icon: "🔒",
      items: ["Advanced age", "Female sex", "White / Asian ethnicity", "Family history of hip fracture", "Early menopause (<45 yrs)"]
    },
    {
      title: "Modifiable",
      color: C.amber,
      icon: "✏",
      items: ["Low calcium intake", "Vitamin D deficiency", "Smoking", "Excessive alcohol", "Physical inactivity", "Low body weight"]
    },
    {
      title: "Secondary Causes",
      color: C.coral,
      icon: "💊",
      items: ["Glucocorticoids (>5 mg/day >3 mo)", "Rheumatoid arthritis", "Malabsorption / Celiac disease", "Chronic kidney disease", "Hyperthyroidism / Hypogonadism"]
    }
  ];

  categories.forEach((cat, i) => {
    const cx = 0.3 + i * 3.25;
    // header bar
    s.addShape(pres.shapes.RECTANGLE, {
      x: cx, y: 1.3, w: 3.05, h: 0.55,
      fill: { color: cat.color }, line: { color: cat.color }
    });
    s.addText(`${cat.icon}  ${cat.title}`, {
      x: cx + 0.08, y: 1.3, w: 2.9, h: 0.55,
      fontSize: 13.5, bold: true, color: C.white,
      fontFace: "Calibri", valign: "middle", margin: 0
    });
    // items box
    s.addShape(pres.shapes.RECTANGLE, {
      x: cx, y: 1.85, w: 3.05, h: 3.4,
      fill: { color: C.white }, line: { color: C.lightGray, pt: 1 },
      shadow: { type: "outer", color: "000000", blur: 6, offset: 2, angle: 135, opacity: 0.1 }
    });
    const richItems = cat.items.map((item, j) => ({
      text: `  ${item}`,
      options: { bullet: { code: "25CF" }, breakLine: j < cat.items.length - 1, fontSize: 11.5, color: C.darkText, fontFace: "Calibri" }
    }));
    s.addText(richItems, {
      x: cx + 0.12, y: 1.95, w: 2.82, h: 3.2,
      valign: "top", margin: 0
    });
  });
}

// ─── SLIDE 6: CLINICAL FEATURES ──────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: C.offWhite }, line: { color: C.offWhite } });
  addSlideHeader(s, "Clinical Manifestations", "The Silent Disease");

  // Silent disease banner
  s.addShape(pres.shapes.RECTANGLE, {
    x: 0.35, y: 1.3, w: 9.3, h: 0.58,
    fill: { color: C.teal }, line: { color: C.teal }
  });
  s.addText('⚠  "Silent Disease" — Bone loss occurs WITHOUT symptoms until fracture occurs  ⚠', {
    x: 0.35, y: 1.3, w: 9.3, h: 0.58,
    fontSize: 13, bold: true, color: C.white, fontFace: "Calibri",
    align: "center", valign: "middle", margin: 0
  });

  // Fracture type cards
  const fractures = [
    { title: "Vertebral Fractures", sub: "Most Common", body: "70% asymptomatic\nHeight loss & kyphosis\n'Dowager's hump'\nBackache", color: C.coral, icon: "🦴" },
    { title: "Hip Fractures", sub: "Most Serious", body: "High mortality in elderly\nMajor disability\nRequires surgery\nLong recovery", color: C.amber, icon: "🏥" },
    { title: "Wrist Fractures", sub: "Often First Sign", body: "Colles' fracture\nFall on outstretched hand\nAlerts to further risk\nCommon age 50-60s", color: C.tealLight, icon: "✋" },
    { title: "Other Sites", sub: "Widespread Risk", body: "Humerus, pelvis, ribs\n1 in 6 fractures in\nnormal bone density\nMultiple fracture risk", color: C.teal, icon: "📍" },
  ];
  fractures.forEach((f, i) => {
    const cx = 0.3 + i * 2.4;
    s.addShape(pres.shapes.RECTANGLE, {
      x: cx, y: 2.05, w: 2.25, h: 3.2,
      fill: { color: C.white }, line: { color: f.color, pt: 1.5 },
      shadow: { type: "outer", color: "000000", blur: 7, offset: 2, angle: 135, opacity: 0.12 }
    });
    // Top accent
    s.addShape(pres.shapes.RECTANGLE, {
      x: cx, y: 2.05, w: 2.25, h: 0.58,
      fill: { color: f.color }, line: { color: f.color }
    });
    s.addText(f.icon, {
      x: cx, y: 2.05, w: 0.65, h: 0.58,
      fontSize: 18, fontFace: "Segoe UI Emoji",
      align: "center", valign: "middle", margin: 0
    });
    s.addText(f.title, {
      x: cx + 0.62, y: 2.05, w: 1.6, h: 0.34,
      fontSize: 11, bold: true, color: C.white, fontFace: "Calibri", valign: "top", margin: 0
    });
    s.addText(f.sub, {
      x: cx + 0.62, y: 2.37, w: 1.6, h: 0.26,
      fontSize: 9, color: C.white, fontFace: "Calibri", italic: true, valign: "top", margin: 0
    });
    s.addText(f.body, {
      x: cx + 0.12, y: 2.72, w: 2.0, h: 2.4,
      fontSize: 11, color: C.darkText, fontFace: "Calibri", valign: "top", margin: 0
    });
  });
}

// ─── SLIDE 7: DIAGNOSIS ───────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: C.offWhite }, line: { color: C.offWhite } });
  addSlideHeader(s, "Diagnosis", "DXA, FRAX & Vertebral Imaging");

  // Left column: DXA
  s.addShape(pres.shapes.RECTANGLE, {
    x: 0.3, y: 1.35, w: 4.5, h: 4.0,
    fill: { color: C.navy }, line: { color: C.navy },
    shadow: { type: "outer", color: "000000", blur: 10, offset: 3, angle: 135, opacity: 0.2 }
  });
  s.addShape(pres.shapes.RECTANGLE, {
    x: 0.3, y: 1.35, w: 4.5, h: 0.07,
    fill: { color: C.tealLight }, line: { color: C.tealLight }
  });
  s.addText("🔬  DXA Scan — Gold Standard", {
    x: 0.45, y: 1.42, w: 4.2, h: 0.5,
    fontSize: 14, bold: true, color: C.tealLight, fontFace: "Calibri", valign: "middle", margin: 0
  });
  const dxaPoints = [
    "Measures BMD at hip & lumbar spine",
    "Results as T-score (vs young adults) or Z-score (vs age-matched)",
    "Screening: all women ≥65 yrs; men ≥70 yrs",
    "Also used for Vertebral Fracture Assessment (VFA)",
    "Trabecular Bone Score (TBS) — additional microarchitecture estimate",
  ];
  const dxaRich = dxaPoints.map((p, j) => ({
    text: `  ${p}`,
    options: { bullet: { code: "25B6" }, breakLine: j < dxaPoints.length - 1, fontSize: 11.5, color: C.white, fontFace: "Calibri" }
  }));
  s.addText(dxaRich, { x: 0.45, y: 2.0, w: 4.1, h: 3.2, valign: "top", margin: 0 });

  // Right column: FRAX
  s.addShape(pres.shapes.RECTANGLE, {
    x: 5.2, y: 1.35, w: 4.5, h: 4.0,
    fill: { color: C.white }, line: { color: C.lightGray, pt: 1 },
    shadow: { type: "outer", color: "000000", blur: 10, offset: 3, angle: 135, opacity: 0.12 }
  });
  s.addShape(pres.shapes.RECTANGLE, {
    x: 5.2, y: 1.35, w: 4.5, h: 0.07,
    fill: { color: C.coral }, line: { color: C.coral }
  });
  s.addText("📊  FRAX Score", {
    x: 5.35, y: 1.42, w: 4.2, h: 0.5,
    fontSize: 14, bold: true, color: C.coral, fontFace: "Calibri", valign: "middle", margin: 0
  });
  s.addText("10-year fracture probability tool combining:", {
    x: 5.35, y: 1.95, w: 4.1, h: 0.4,
    fontSize: 11.5, color: C.darkText, fontFace: "Calibri", valign: "top", margin: 0
  });
  const fraxFactors = ["Age, sex, BMI", "Prior fracture history", "Family history of hip fracture", "Smoking & alcohol use", "Glucocorticoid use", "Rheumatoid arthritis", "BMD (optional)"];
  const fraxRich = fraxFactors.map((p, j) => ({
    text: `  ${p}`,
    options: { bullet: { code: "25CF" }, breakLine: j < fraxFactors.length - 1, fontSize: 11, color: C.darkText, fontFace: "Calibri" }
  }));
  s.addText(fraxRich, { x: 5.35, y: 2.4, w: 4.0, h: 1.8, valign: "top", margin: 0 });

  // Treatment thresholds box
  s.addShape(pres.shapes.RECTANGLE, {
    x: 5.2, y: 4.2, w: 4.5, h: 0.88,
    fill: { color: C.coral }, line: { color: C.coral }
  });
  s.addText("US Treatment Thresholds (FRAX):\n≥20% major osteoporotic fracture  |  ≥3% hip fracture", {
    x: 5.3, y: 4.22, w: 4.3, h: 0.84,
    fontSize: 11.5, bold: true, color: C.white, fontFace: "Calibri",
    align: "center", valign: "middle", margin: 0
  });
}

// ─── SLIDE 8: TREATMENT ───────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: C.navy }, line: { color: C.navy } });
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 0, w: 10, h: 1.15, fill: { color: "091D30" }, line: { color: "091D30" } });
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 1.15, w: 10, h: 0.07, fill: { color: C.amber }, line: { color: C.amber } });
  s.addText("Treatment & Management", {
    x: 0.4, y: 0.1, w: 9.2, h: 0.7, fontSize: 26, bold: true, color: C.white, fontFace: "Calibri", valign: "middle", margin: 0
  });
  s.addText("Non-Pharmacological & Pharmacological Interventions", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.38, fontSize: 13, color: C.amber, fontFace: "Calibri", italic: true, valign: "middle", margin: 0
  });

  // Non-pharma column
  s.addShape(pres.shapes.RECTANGLE, {
    x: 0.3, y: 1.35, w: 3.5, h: 4.0,
    fill: { color: "112233" }, line: { color: C.tealLight, pt: 1.5 }
  });
  s.addShape(pres.shapes.RECTANGLE, {
    x: 0.3, y: 1.35, w: 3.5, h: 0.5,
    fill: { color: C.tealLight }, line: { color: C.tealLight }
  });
  s.addText("Lifestyle Measures", {
    x: 0.45, y: 1.35, w: 3.2, h: 0.5,
    fontSize: 13, bold: true, color: C.white, fontFace: "Calibri", valign: "middle", margin: 0
  });
  const lifestyle = [
    "🥛  Calcium: 1,000-1,200 mg/day",
    "☀   Vitamin D: 800-1,000 IU/day",
    "🏃  Weight-bearing exercise",
    "🚭  Smoking cessation",
    "🍷  Limit alcohol intake",
    "🏠  Fall prevention at home",
    "⚖   Maintain healthy body weight",
  ];
  const lsRich = lifestyle.map((p, j) => ({
    text: p,
    options: { breakLine: j < lifestyle.length - 1, fontSize: 11.5, color: C.white, fontFace: "Calibri" }
  }));
  s.addText(lsRich, { x: 0.45, y: 1.95, w: 3.25, h: 3.2, valign: "top", margin: 0 });

  // Pharma drugs table
  const drugs = [
    { cls: "Bisphosphonates (1st line)", ex: "Alendronate, Risedronate, Zoledronic acid", mech: "Inhibit osteoclast resorption", col: C.teal },
    { cls: "Denosumab", ex: "Prolia", mech: "Anti-RANKL monoclonal antibody", col: C.tealLight },
    { cls: "Anabolics", ex: "Teriparatide, Abaloparatide", mech: "PTH analogs — stimulate formation", col: C.amber },
    { cls: "Romosozumab", ex: "Evenity", mech: "Anti-sclerostin — dual action", col: C.coral },
    { cls: "SERMs / HRT", ex: "Raloxifene / Estrogen", mech: "Reduce bone resorption", col: "8E44AD" },
  ];

  // Table header
  s.addShape(pres.shapes.RECTANGLE, {
    x: 4.1, y: 1.35, w: 5.6, h: 0.42,
    fill: { color: C.amber }, line: { color: C.amber }
  });
  ["Drug Class", "Example", "Mechanism"].forEach((h, i) => {
    const wx = [0, 1.65, 3.3];
    s.addText(h, {
      x: 4.15 + wx[i], y: 1.35, w: i === 0 ? 1.6 : i === 1 ? 1.6 : 1.95, h: 0.42,
      fontSize: 11, bold: true, color: C.navy, fontFace: "Calibri", valign: "middle", margin: 2
    });
  });

  drugs.forEach((d, i) => {
    const ry = 1.77 + i * 0.62;
    const bg = i % 2 === 0 ? "0F2035" : "152840";
    s.addShape(pres.shapes.RECTANGLE, {
      x: 4.1, y: ry, w: 5.6, h: 0.62,
      fill: { color: bg }, line: { color: bg }
    });
    // Left accent
    s.addShape(pres.shapes.RECTANGLE, {
      x: 4.1, y: ry, w: 0.055, h: 0.62,
      fill: { color: d.col }, line: { color: d.col }
    });
    s.addText(d.cls, {
      x: 4.18, y: ry, w: 1.58, h: 0.62,
      fontSize: 10, bold: true, color: d.col, fontFace: "Calibri", valign: "middle", margin: 2
    });
    s.addText(d.ex, {
      x: 5.78, y: ry, w: 1.58, h: 0.62,
      fontSize: 10, color: C.white, fontFace: "Calibri", valign: "middle", margin: 2
    });
    s.addText(d.mech, {
      x: 7.4, y: ry, w: 2.2, h: 0.62,
      fontSize: 10, color: C.lightGray, fontFace: "Calibri", valign: "middle", margin: 2
    });
  });
}

// ─── SLIDE 9: KEY SUMMARY ──────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: C.navy }, line: { color: C.navy } });

  // Title
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 0, w: 10, h: 1.0, fill: { color: "091D30" }, line: { color: "091D30" } });
  s.addShape(pres.shapes.RECTANGLE, { x: 0, y: 1.0, w: 10, h: 0.07, fill: { color: C.tealLight }, line: { color: C.tealLight } });
  s.addText("Key Takeaways", {
    x: 0.4, y: 0.12, w: 9.2, h: 0.75,
    fontSize: 28, bold: true, color: C.white, fontFace: "Calibri", valign: "middle", margin: 0
  });

  const points = [
    { num: "01", text: "Osteoporosis = reduced bone mass + microarchitectural deterioration → fragility fractures", col: C.coral },
    { num: "02", text: "Defined by WHO as T-score ≤ -2.5 on DXA; T-score -1.0 to -2.5 = Osteopenia", col: C.amber },
    { num: "03", text: "Driven by RANKL/RANK imbalance & Wnt pathway disruption favoring resorption over formation", col: C.tealLight },
    { num: "04", text: "Vertebral fractures most common (70% asymptomatic); hip fractures most dangerous", col: "27AE60" },
    { num: "05", text: "FRAX tool estimates 10-year fracture risk; treatment if hip ≥3% or major fracture ≥20%", col: C.amber },
    { num: "06", text: "Treatment: calcium + vitamin D + exercise + bisphosphonates (first-line pharmacotherapy)", col: C.tealLight },
  ];

  points.forEach((p, i) => {
    const col = i % 2 === 0 ? 0.3 : 5.15;
    const ry = 1.2 + Math.floor(i / 2) * 1.35;

    s.addShape(pres.shapes.OVAL, {
      x: col, y: ry, w: 0.65, h: 0.65,
      fill: { color: p.col }, line: { color: p.col }
    });
    s.addText(p.num, {
      x: col, y: ry, w: 0.65, h: 0.65,
      fontSize: 13, bold: true, color: C.white, fontFace: "Calibri",
      align: "center", valign: "middle", margin: 0
    });
    s.addText(p.text, {
      x: col + 0.75, y: ry, w: 3.9, h: 0.65,
      fontSize: 11.5, color: C.white, fontFace: "Calibri", valign: "middle", margin: 0
    });
  });

  // Footer
  s.addShape(pres.shapes.RECTANGLE, {
    x: 0, y: 5.22, w: 10, h: 0.38,
    fill: { color: C.coral }, line: { color: C.coral }
  });
  s.addText("Source: Harrison's Principles of Internal Medicine 22E (2025)  |  Rheumatology 2-Volume Set (2022, Elsevier)", {
    x: 0, y: 5.22, w: 10, h: 0.38,
    fontSize: 9.5, color: C.white, fontFace: "Calibri", align: "center", valign: "middle", margin: 0
  });
}

// ─── WRITE ────────────────────────────────────────────────────────────────────
pres.writeFile({ fileName: "/home/daytona/workspace/osteoporosis-ppt/Osteoporosis.pptx" })
  .then(() => console.log("Done: Osteoporosis.pptx"))
  .catch(err => { console.error(err); process.exit(1); });

Running Command

cd /home/daytona/workspace/osteoporosis-ppt && node create_ppt.js 2>&1

Running Command

ls -lh /home/daytona/workspace/osteoporosis-ppt/Osteoporosis.pptx

Your presentation is ready! Here's the download link:

Osteoporosis

Presentation · PPTX

What's inside - 9 slides with a Navy + Teal + Coral color palette:

Slide	Topic	Design
1	Title	Dark hero layout with decorative circles, pill tags
2	Definition & Classification	WHO T-score 4-color classification cards
3	Epidemiology	Big stat blocks (10.8M, $19B, 2M fractures...)
4	Pathophysiology	3-column dark flow diagram (RANKL → Imbalance → Microarchitecture loss)
5	Risk Factors	3 category columns (Non-modifiable / Modifiable / Secondary)
6	Clinical Manifestations	4 fracture-type cards with icons + "Silent Disease" banner
7	Diagnosis	DXA gold standard + FRAX score with treatment thresholds
8	Treatment	Lifestyle column + colour-coded pharmacotherapy table
9	Key Takeaways	6 numbered summary points with accent circles

All content sourced from Harrison's Principles of Internal Medicine 22E and Rheumatology 2-Volume Set (Elsevier, 2022).

This is a shared conversation. Sign in to Orris to start your own chat.